# Study Evaluating Brompheniramine Maleate Liquid in Children and Adolescents

> **NCT00894634** · PHASE1 · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 37 (actual)

## Conditions studied

- Allergic Reactions

## Interventions

- **DRUG:** Brompheniramine maleate

## Key facts

- **NCT ID:** NCT00894634
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-03-21
- **Primary completion:** 2009-04-26
- **Final completion:** 2009-04-26
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2020-10-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00894634

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00894634, "Study Evaluating Brompheniramine Maleate Liquid in Children and Adolescents". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00894634. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*